News Digging > Popular > U.S. Food and Drug Administration approves CSL’s HEMGENIX , first gene therapy for hemophilia B
U.S. Food and Drug Administration approves CSL’s HEMGENIX , first gene therapy for hemophilia B
U.S. Food and Drug Administration approves CSL's HEMGENIX , first gene therapy for hemophilia B,This historic approval provides a new treatment option that reduces the rate of annual bleeds, reduces or eliminates the need for prophylactic therapy

U.S. Food and Drug Administration approves CSL’s HEMGENIX , first gene therapy for hemophilia B

This historic approval provides a new treatment option that reduces the rate of annual bleeds, reduces or eliminates the need for prophylactic therapy